Related Experiment Videos
[Multiple myeloma and HIV/AIDS infection. Three case reports]
A Elira Dokekias1, M F Purhuence, F Malanda
1Service hématologie, CHU Brazzaville-Congo.
La Tunisie Medicale
|May 6, 2004
Summary
This study reports three cases of women with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) and multiple myeloma. The findings suggest a potential link between HIV/AIDS and the development of this blood cancer.
Area of Science:
- Hematology
- Oncology
- Infectious Diseases
Background:
- Sub-Saharan Africa faces endemic Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) rates.
- Co-occurrence of HIV/AIDS and multiple myeloma presents diagnostic and therapeutic challenges.
Observation:
- Three female patients with HIV/AIDS and multiple myeloma admitted to the University Hospital of Brazzaville between 2000-2002.
- Multiple myeloma was diagnosed after HIV/AIDS in two cases and before in one case.
- All patients presented symptomatic HIV/AIDS, with advanced-stage multiple myeloma (IgG or IgA types).
Findings:
- T4 lymphocyte counts varied, with one patient on antiviral therapy showing 390 cells/mm³.
- Polychemotherapy (VMCP/VAMCP) was administered with anti-infective prophylaxis, without major complications.
- Short-term outcomes were insufficient to determine long-term prognosis for the blood malignancy.
Implications:
- These observations support the role of human retroviruses, specifically HIV/AIDS, in lymphomagenesis.
- Further research is needed to understand the prognostic implications and therapeutic strategies for co-infected patients.
- Highlights the importance of considering hematologic malignancies in HIV-positive individuals.